Phenotype, penetrance, and treatment of 133 cytotoxic T‐lymphocyte antigen 4–insufficient subjects

[1]  Q. Pan-Hammarström,et al.  Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity. , 2018, Clinical immunology.

[2]  T. Chatila,et al.  CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder. , 2017, The Journal of allergy and clinical immunology.

[3]  A. Worth,et al.  Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. , 2017, Blood.

[4]  M. Mehling,et al.  Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. , 2017, The Journal of allergy and clinical immunology.

[5]  T. Torgerson,et al.  Hematopoietic stem cell transplantation for CTLA4 deficiency. , 2016, The Journal of allergy and clinical immunology.

[6]  F. Rieux-Laucat,et al.  LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis. , 2016, Clinical immunology.

[7]  J. Henter,et al.  Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation , 2016, Journal of Clinical Immunology.

[8]  B. Grimbacher,et al.  Infancy-Onset T1DM, Short Stature, and Severe Immunodysregulation in Two Siblings With a Homozygous LRBA Mutation. , 2016, The Journal of clinical endocrinology and metabolism.

[9]  T. Morio,et al.  The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. , 2016, The Journal of allergy and clinical immunology.

[10]  M. Corr.  Faculty Opinions recommendation of AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. , 2015 .

[11]  J. Hughes,et al.  Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy , 2015, Science.

[12]  A. Borkhardt,et al.  Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. , 2015, Clinical immunology.

[13]  A. Deutschmann,et al.  Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency , 2015, The Journal of allergy and clinical immunology.

[14]  Elisha D O Roberson,et al.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.

[15]  B. Grimbacher,et al.  Atypical Manifestation of LRBA Deficiency with Predominant IBD-like Phenotype , 2015, Inflammatory bowel diseases.

[16]  Toshiro K. Ohsumi,et al.  Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. , 2015, The Journal of allergy and clinical immunology.

[17]  R. Geha,et al.  Spectrum of Phenotypes Associated with Mutations in LRBA , 2015, Journal of Clinical Immunology.

[18]  V. Hwa,et al.  A Successful HSCT in a Girl with Novel LRBA Mutation with Refractory Celiac Disease , 2015, Journal of Clinical Immunology.

[19]  O. Ohara,et al.  A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer , 2015, Journal of Clinical Immunology.

[20]  A. Franke,et al.  Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4 , 2014, Gut.

[21]  A. Schäffer,et al.  Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations , 2014, Nature Medicine.

[22]  J. B. Oliveira,et al.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 , 2014, Science.

[23]  J. Kere,et al.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease , 2014, Nature Genetics.

[24]  J. Casanova,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2015, Journal of Clinical Immunology.

[25]  L. Walker.  Treg and CTLA-4: Two intertwining pathways to immune tolerance , 2013, Journal of autoimmunity.

[26]  S. Nejentsev,et al.  LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. , 2012, The Journal of allergy and clinical immunology.

[27]  R. Geha,et al.  LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. , 2012, The Journal of allergy and clinical immunology.

[28]  R. Bacchetta,et al.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..

[29]  Bodo Grimbacher,et al.  Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. , 2012, American Journal of Human Genetics.

[30]  L. Walker,et al.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses , 2011, Nature Reviews Immunology.

[31]  G. Anderson,et al.  Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4 , 2011, Science.

[32]  Steven M. Holland,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2009, Front. Immun..

[33]  J. B. Oliveira,et al.  Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. , 2010, Blood.

[34]  J. Bluestone,et al.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells , 2009, Immunological reviews.

[35]  R. Friedline,et al.  CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance , 2009, The Journal of experimental medicine.

[36]  T. Nomura,et al.  CTLA-4 Control over Foxp3+ Regulatory T Cell Function , 2008, Science.

[37]  Hans D. Ochs,et al.  IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity , 2007, Immunologic research.

[38]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[39]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[40]  Andrea Iaboni,et al.  The interaction properties of costimulatory molecules revisited. , 2002, Immunity.

[41]  A. Fedorov,et al.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.

[42]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[43]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.